Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia. - Savarirayan R; Hoover-Fong J; Irving M; Arundel P; de Bergua JM; Campeau PM; Candler T; Cocanougher BT; Cormier-Daire V; Edouard T; Fredwall SO; Harmatz P; et al. (The New England journal of medicine, 2026)